tirzepatide court UPDATE [March 7, 2025]: OFA takes case to appeals as legal battle evolves FDA's tirzepatide decision creates uncertainty court ruling on tirzepatide case – F.D.A. Approves New Obesity Drug

The judge, who presided over a four-week, non-jury trial conducted over Zoom, ordered Bristol-Myers and Sanofi to pay US$ 417 million each in penalties

How Merit compares to the two alternatives most research buyers consider for Tirzepatide

While compounded GLP-1 injections may appear more affordable, they often lack standardized testing and consistency

We administered a single dose of cannabis and did not have blood glucose measurements

There are at least 4 separate studies in progress which need to be completed before the drug can be properly reviewed by regulatory bodies

Should the court rule in our favor, it is likely an award amount will be assigned to you based on the extent of the damages you sustained